Context Therapeutics GAAP EPS of -$0.31

straga/iStock via Getty Images U.S. liquefied natural gas developers are on track to win approval of three new export projects{...}

Publisher Will Lewis steps down from Washington Post after major layoffs Source link{...}

Axogen gets FDA OK for Avance’s biologics license application Source link{...}